Rhokiinsa Eiropas Savienība - latviešu - EMA (European Medicines Agency)

rhokiinsa

santen oy - netarsudil - glaucoma, open-angle; ocular hypertension - oftalmoloģiskie līdzekļi - samazināt paaugstinātu intraokulāro spiedienu (ias) pieaugušiem pacientiem ar primāra atvērta kakta glaukoma vai acs hipertensijas.

Recarbrio Eiropas Savienība - latviešu - EMA (European Medicines Agency)

recarbrio

merck sharp & dohme b.v.  - imipenem monohidrāts, cilastatin nātrija, relebactam monohidrāts - gram-negatīvo baktēriju infekcijas - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 un 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4. un 5.. jāņem vērā oficiālās vadlīnijas par piemērotu izmantot antibakteriālas vielas.

Stelfonta Eiropas Savienība - latviešu - EMA (European Medicines Agency)

stelfonta

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - suņi - par attieksmi pret trešo resectable, kas nav metastātisku (kas inscenējums) zemādas tuklo šūnu audzēji, kas atrodas vai distālo līdz elkonim vai ieķīlāt, un ne-resectable, kas nav metastātisku ādas tuklo šūnu audzēji ar suņiem.

Cefazolin PharmSol 1000 mg pulveris injekciju/infūziju šķīduma pagatavošanai Latvija - latviešu - Zāļu valsts aģentūra

cefazolin pharmsol 1000 mg pulveris injekciju/infūziju šķīduma pagatavošanai

pharmsol europe limited, malta - cefazolīns - pulveris injekciju/infūziju šķīduma pagatavošanai - 1000 mg

Leqvio Eiropas Savienība - latviešu - EMA (European Medicines Agency)

leqvio

novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - lipīdu modificējoši aģenti - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.

OvuGel Eiropas Savienība - latviešu - EMA (European Medicines Agency)

ovugel

vetoquinol - triptorelin acetate - hipofīzes un hipotalāma hormoni un analogi - pigs (sows for reproduction) - for the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.

Byooviz Eiropas Savienība - latviešu - EMA (European Medicines Agency)

byooviz

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmoloģiskie līdzekļi - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Zenalpha Eiropas Savienība - latviešu - EMA (European Medicines Agency)

zenalpha

vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - psiholētikas, hipnotikas un sedatīvi līdzekļi - suņi - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.

Tabrecta Eiropas Savienība - latviešu - EMA (European Medicines Agency)

tabrecta

novartis europharm limited  - capmatinib dihydrochloride monohydrate - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Cessolute 70 mg/g + 70 mg/g krēms Latvija - latviešu - Zāļu valsts aģentūra

cessolute 70 mg/g + 70 mg/g krēms

egis pharmaceuticals plc, hungary - lidocainum, tetracainum - krēms - 70 mg/g + 70 mg/g